Important Notice for Organon & Co. Shareholders About Upcoming Class Action Lawsuit

Notice to Organon & Co. Shareholders

The Gross Law Firm is reaching out to the shareholders of Organon & Co. (NYSE: OGN) regarding an important class action lawsuit. This legal action addresses the repercussions of misleading statements allegedly made by the company's executives regarding its financial practices and capital allocation. Shareholders who acquired shares during the specified class period are encouraged to take action.

Class Period and Allegations

The class period for this lawsuit extends from October 31, 2024, to April 30, 2025. During this timeframe, it is alleged that Organon's management conveyed overly optimistic information about the company's financial health while simultaneously downplaying significant adverse facts. Notably, information concerning the prioritization of debt reduction over quarterly dividend payments was allegedly concealed, which led to a shocking 70% cut in dividends after the company's acquisition of Dermavant.

The consequences were stark. Following the news of these misleading practices, Organon's stock plummeted from a market price of $12.93 per share on April 30, 2025, to $9.45 on May 1, 2025, marking a dramatic loss of over 27% within a single day. Such a steep decline raised alarms for investors who felt misled by the previous reassurances from the company.

Important Deadlines

For those affected, it is crucial to act swiftly. The deadline for registering as a potential lead plaintiff in this class action is July 22, 2025. Interested shareholders can register through a dedicated link provided, ensuring they secure their right to participate in any potential recovery.

Shareholders are reminded that participation in the class action does not necessitate serving as a lead plaintiff. Once registered, individuals will gain access to a portfolio monitoring service, which will keep them informed of the case's progress and developments.

Why Choose The Gross Law Firm?

The Gross Law Firm is a nationally recognized entity dedicated to advocating for the rights of investors impacted by corporate fraud and unethical practices. Their commitment lies in holding companies accountable for misleading their shareholders and preserving good corporate governance. The firm offers no-cost participation for affected investors, pointing towards their overarching goal of restoring investors' trust and financial stability.

If you invested in Organon during the class period, it is imperative to stay informed and take necessary action. For additional information or to start the registration process, visit the link provided, and do not miss the opportunity to potentially reclaim your losses.

Contact Information

For inquiries or further assistance, investors can reach out to:
The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY 10018
Email: ([email protected])
Phone: (646) 453-8903

Stay vigilant about your investments and protect your rights as a shareholder.